Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.40    0.20 (0.07%)
Bid:
304.80
Ask:
305.20
Spread: 0.40 (0.131%)
Market Cap: £2.48b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

21 Nov 2019 07:00

RNS Number : 1283U
Rotork PLC
21 November 2019
 

Rotork Plc

Trading update

Rotork plc ("Rotork"), the global flow control and instrumentation company, issues the following trading update covering the four months to 27 October 2019.

Order intake showed improvement on the 2018 third quarter comparator period on an organic constant currency¹ ("OCC") basis, and was also ahead on a year-to-date basis. Rotork's customers have continued to spend on maintenance and repair as well as upgrade, modernisation and automation whilst large project activity has remained subdued. A slightly greater than usual proportion of recent orders are not for delivery until next year. We therefore now expect to deliver modestly lower OCC sales year-on-year in 2019, reflecting order phasing, portfolio and product rationalisation, and the impact on the prior year from delivery of several significant projects and sales to countries subsequently placed under sanction.

Full year adjusted operating margins are expected to show good progress year-on-year benefiting from continued execution of the Growth Acceleration Programme and mix. We expect reported 2019 adjusted operating profit to be in-line with management expectations on an OCC basis. We note that sterling has strengthened since our interim results.

Our Growth Acceleration Programme is on track. Our end market reorganisation continues with the rollout to Asia Pacific completed and Europe, Middle East & Africa now well underway. Our Value Selling initiative is ongoing, with over half of our sales people having already completed the training. We have made further progress driving lean improvements and reducing inventory levels. We have completed the IT system design stage and we plan to launch the global HR platform ahead of plan before the end of the year.

Rotork remains highly cash generative with a strong balance sheet. Net cash at 27 October 2019 was £66.9m (£31.6m at 31 December 2018 including £12.0m of lease liabilities).

Rotork will publish 2019 full-year results on Tuesday 3 March 2020.

¹ OCC is organic constant currency results excluding discontinued businesses and restated at 2018 exchange rates

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVTLLLIFIA
Date   Source Headline
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
13th Feb 20243:30 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
11th Jan 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:00 amRNSTotal Voting Rights
20th Dec 20235:17 pmRNSDirector Declaration
13th Dec 20233:30 pmRNSDirector/PDMR Shareholding
13th Dec 202311:00 amRNSDirector Declaration
11th Dec 20233:30 pmRNSDirector/PDMR Shareholding
1st Dec 20233:30 pmRNSTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20233:30 pmRNSDirector/PDMR Shareholding
1st Nov 20233:00 pmRNSTotal Voting Rights
11th Oct 20233:30 pmRNSDirector/PDMR Shareholding
9th Oct 20233:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSTotal Voting Rights
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSDirectorate Change – CFO Transition
7th Sep 202311:45 amRNSDirectorate Change
4th Sep 20234:03 pmRNSTotal Voting Rights
14th Aug 20234:30 pmRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:36 pmRNSTotal Voting Rights
11th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:30 amRNSTotal Voting Rights
29th Jun 202310:45 amRNSDirectorate Change
19th Jun 202311:00 amRNSDirector Declaration
14th Jun 20233:30 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
8th Jun 202312:26 pmRNSTotal Voting Rights
15th May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:15 pmRNSTotal Voting Rights
28th Apr 20233:45 pmRNSDirector/PDMR Shareholding
28th Apr 20233:22 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Update
12th Apr 20233:00 pmRNSDirector/PDMR Shareholding
6th Apr 20234:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
29th Mar 20232:30 pmRNSDirector/PDMR Shareholding
27th Mar 20236:21 pmRNSDirector/PDMR Shareholding
24th Mar 20233:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20234:46 pmRNS2022 Annual Report and Notice of 2023 AGM
15th Mar 20234:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20233:30 pmRNSDirector/PDMR Shareholding
7th Mar 202311:00 amRNSDirector/PDMR Shareholding
1st Mar 20233:00 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Preliminary Results
13th Feb 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.